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Abstract
INTRODUCTION: Acute mesenteric ischemia (AMI) is an abdominal-vascular emergency which is rare and has 
high mortality rates (60–80 %) due to late diagnosis (1–3). Although it is known that extravascular reasons like 
intestinal intussusception, volvulus, strangulated hernias and obstructions can cause intestinal gangrene, these 
are rarely the cause of AMI (1). 
MATERIALS AND METHODS: In this study, we used male Wistar-Albino rats weighing 250–300 grams obtained 
from Pamukkale University Experimental Research Laboratory. Animals were exposed to light-dark cycles for 12 
hours and had free access to food and water. They were kept in cages for 7 days to stabilise their intestinal fl ora. 
In animals of group I, nothing was made other than taking 0.5 ml blood intracardially. In other animals, abdomen 
was reached with midline laparotomy and superior mesenteric artery (SMA) was located. In group II (operative 
control group), SMA was isolated and manipulated but was not ligated. In Group III (intestinal ischemia group), 
SMAwas isolated and ligated with 3/0 silk tie distally to the aorta. After this process, intestinal ischemia was 
achieved which was confi rmed by paleness and pulselessness of intestines, caecum and right colon. Later on, 
abdomen was closed with double 3/0 polyglactin sutures. At postoperative 1st, 4th and 6th hours 0.5 ml blood 
was taken intracardially from the animals in groups II and III in order to quantify D-dimer and L-lactate levels. 
LABORATORY TESTS: D-dimer: Blood samples which were put into tubes containing sodium citrate, were 
seperated from plasma with centrifugation at 4000 rpm for 7 minutes.
L-lactate: Blood L-lactate levels were determined from blood taken into capillary tubes with the help of immo-
bilised enzyme electrode technology using YSI 1500 Sport portative lactate analyzer (Yellow Springs Instru-
ments Inc., Ohio-USA).
HISTOPATHOLOGIC VERIFICATION: Two cm long intestinal samples were taken from animals in which SMA 
was ligated in order to achieve mesenteric ischemia and these samples were fi xed in 10 % formol.
DISCUSSION: As a result, in rats with SMA occlusion serum D-dimer levels were not increased signifi cantly 
when compared either in the group or with the basal values of the control group and values in operative control 
group. Therefore, it is concluded that D-dimer is not a useful marker for early diagnosis of AMI. On the other 
hand, it is revealed that blood L-lactate levels began to increase signifi cantly following 4th hour of mesenteric 
ischemia and it is shown that this increase continued at the 6th hour. In addition, considering the utmost im-
portance of the early diagnosis in patients with the clinical suspicion of AMI, L-lactate seems to be a suitable 
marker to use in emergency departments because it is achieved with a portable device that gives fast and ac-
curate results. Nevertheless, our results are need to be supported by clinical studies with larger patient series 
(Tab. 2, Fig. 11, Ref. 39). Text in PDF www.elis.sk.
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Introduction
Acute mesenteric ischemia (AMI) is an abdominal-vascular 
emergency which is rare and has high mortality rates (60–80 %) 
due to late diagnosis (1–3). AMI is seen in one out of thousand but 
the incidence is increasing (4). Although it is known that extravas-
cular reasons like intestinal intussusception, volvulus, strangulated 
hernias and obstructions can cause intestinal gangrene, these are 
rarely the cause of AMI (1). The etiology of AMI can be evaluated 
in 4 sub-categories: superior mesenteric artery (SMA) embolism 
(45–50 %), thrombosis of SMA (25 %), superior mesenteric vein 
(SMV) thrombosis (5–10 %), and non-occlusive mesenteric isch-
emia (NOMI) (20 %) (4–7). Despite the differences in its etiology, 
intestinal gangrene and necrosis is the fatal end of AMI (3, 7).
Despite the improvements at diagnostic imaging methods, 
surgical techniques and perioperative intensive care support, the 
high mortality rate due to AMI did not change signifi cantly in the 
last seven decades (5, 7). Reason of this are the ongoing diffi cul-
ties at establishing AMI diagnosis before bowel necrosis occurs 
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(7). In a review of Herbert et al, it is reported that only one third of 
the patients was diagnosed as AMI before the surgical exploration 
and death (5). In Swedish autopsy studies, it was shown that real 
mortality rate from mesenteric ischemia can be more than 90 %, 
and 22–32 % of these patients could be diagnosed before death 
(8, 9). It is known that delays at establishing the AMI diagnosis 
reduce the survival chance and morbidity (4). Patient presentation 
is usually non-spesifi c and normal physical examination of the ab-
domen can cause a dangerous safety feeling of the physician (4, 5).
For early diagnosis of AMI, recent radiological imaging meth-
ods play a limited role. X-rays are non-specifi c and are used to 
exclude reasons of acute abdomen like perforated peptic ulcus. 
Computerized tomography (CT) can show thickening of bowel 
walls, ascites or mesenteric artery obstruction but these all are 
non-specifi c fi ndings which can be seen in the late stages of in-
testinal ischemia (3). Even though Doppler ultrasonography is 
useful in complete obstruction of proximal SMA, it is suboptimal 
because it relies on the expertness of the practitioner (4). Selec-
tive mesenteric angiography is considered the golden standart of 
AMI diagnosis but it is not available at every hospital, it requires 
an interventional radiologist, it is an invasive and long procedure 
and it requires nephrotoxic agents (3–5).
Unfortunately, there are no laboratory tests which can be used 
in early diagnosis of AMI properly. Even though serum amylase, 
aspartate aminotransferase (AST), lactate dehydrogenase (LDH) 
and creatine phosphokinase (CPK) are elevated, none of these are 
sensitive or specifi c (7). There are a lot of studies investigating 
the serum levels of D-dimer, alpha-glutathion S-transferase, D-
lactate, L-lactate, LDH, intestinal fatty acid binding protein, al-
kaline phosphatase and CPK for early diagnosis of AMI but there 
are controversial reports about the usage of these markers in early 
diagnosis of instestinal ischaemia (10–14).
D-dimer is a fi brin degradation product and it can rise in con-
ditions like disseminated intravascular coagulation (DIC), deep 
vein thrombosis and pulmonary embolism as a stable component 
of the fi brinolytic system (10, 12, 15, 16). L-lactate is constantly 
produced from pyruvate via the enzyme lactate dehydrogenase 
(LDH) during anaerobic glycolysis (14). Clinically, it is reported 
that lactate levels are elevated in 90 % of AMI patients and these 
levels are associated with mortality (4). In an experimental study, 
signifi cant elevation of L-lactate levels were seen in rats with SMA 
occlusion (16). In another experimental study, there was no signifi -
cant elevation of L-lactate levels after SMA occlusion (11). The 
aim of this study was to investigate serum D-dimer and L-lactate 
levels in rats with superior mesenteric artery occlusion model.
Materials and methods
In this study, we used male Wistar-Albino rats weighing 250–
300 grams obtained from Pamukkale University Experimental Re-
search Laboratory. Animals were exposed to light-dark cycles for 
12 hours and had free access to food and water. They were kept 
in cages for 7 days to stabilise their intestinal fl ora. Before the 
study, consent was taken from the Pamukkale University Medical 
Faculty Experimental Studies Ethics Committee and all operative 
procedures, usage of anaesthesia and animal care processes were 
done according to the universally accepted guidelines (National 
Institutes of Health Guidelines on the Care and Use of Labora-
tory Animals, NIH publication No.86-23, revised 1985, Bethesda, 
Maryland, ABD).
Animals were randomised into 3 groups which had 10 ani-
mals in each: 
Group I: Non-operative control group: In these animals, only 
blood was taken to spot basal D-dimer and L-lactate levels.
Group II: Operative control group: In these animals, no blood 
was taken before the surgical procedure. SMA was identifi ed and 
manipulated elementarily after the laparotomy.
Group III: Intestinal ischemia group: In these animals, in-
testinal ischemia was created by SMA ligation after laparotomy.
Operational details
After fasting over night, animals were anesthetized using 50 
mg/kg intramuscular ketamine (Ketalar; Eczacibasi Ilac ve Ticaret 
A.S. Istanbul – Turkey) and 10 mg/kg xylazine (Rompun; Bayer 
Türk Kimya San. Ltd. Sti. Istanbul – Turkey). During surgical pro-
cedure, spontaneous ventilation of the rats was ensured. A heater 
lamp was used to keep body temperature at 37 °C. In order to 
prevent dehydration after the surgery, 10 ml Ringer lactate solu-
tion was used subcutaneously. After shaving, abdominal area was 
wiped using 10 % povidone iodine twice and surgery began with 
sterile equipment. In animals in group I, nothing was made other 
than taking 0.5 ml blood intracardially. In other animals, abdomen 
was reached with midline laparotomy and superior mesenteric 
artery (SMA) was located.Int Group II (operative control group), 
SMA was isolated and manipulated but not ligated. In Group III 
(intestinal ischemia group), SMA was isolated and ligated with 
3/0 silk tie distally to the aorta. After this process, intestinal isch-
emia was achieved which was confi rmed by paleness and pulsel-
essness of intestines, caecum and right colon. Later on, abdomen 
was closed with double 3/0 polyglactin sutures. At postoperative 
1st, 4th and 6th hours 0.5 ml blood was taken intracardially from 
the animals in groups II and III in order to quantify D-dimer and 
L-lactate levels. At the end of the experiment, all animals were 
killed by excessive anaesthesia and relaparotomy was performed 
to get intestinal samples. Abominal fi ndings were noted.
Laboratory tests
D-dimer: Blood samples which were put into tubes containing 
sodium citrate, were seperated from plasma with centrifugation at 
4000 rpm for 7 minutes. Immunoturbidimetric assay of fi brin split 
products (D-dimer) was performed using Innovance® D-dimer 
kit and BCS XP System® coagulation analyser (Dade Behring, 
Marburg-Germany). In this method, normal plasma D-dimer levels 
are considered <0.5 mg/L FEU.
L-lactate: Blood L-lactate levels were determined from blood 
taken into capillary tubes with the help of immobilised enzyme 
electrode technology using YSI 1500 Sport portative lactate ana-
lyzer (Yellow Springs Instruments Inc., Ohio-USA). In this tech-
nology, hydrogen peroxide that comes up proportionally to lactate, 
which has been diffused after passing of the blood sample from 
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an enzyme-membrane system, is quantifi ed on a platinum anode. 
Results are displayed as mmol/L. Twenty-fi ve μL blood is enough 
for the measurement. Results are acquired within 60 seconds in 
automatic calibration mode.
Histopathologic verifi cation
Two cm long intestinal samples were taken from animals in 
which SMA was ligated in order to achieve mesenteric ischemia 
and these samples were fi xed in 10 % formol. Materials were em-
bedded in paraffi n, sections at 5 μm were stained with haematox-
ylin-eosin and examined under a light microscope.
Statistical assessment
Data management and statistical analyses were done using 
SPSS for Windows, version 11.5 (SPSS Inc., Chicago, Illinois, 
USA). In groups II and III, intergroup variation comparison of 
D-dimer and L-lactate measurements were done using Friedman 
variation analysis at different time points and p < 0.05 was consid-
ered signifi cant. Results found to be statistically signifi cant with 
this test proceeded to post hoc analysis with Wilcoxon test. More-
over, results between group I and groups II and III were compared 
using Kruskal-Wallis variation analysis and post hoc evaulation 
beetween groups were done using Mann-Whitney U test.
Results
Operative fi ndings
During the perioperative period, 2 rats from superior mesen-
teric artery occlusion group (Group III) died. One of these rats 
died in the fi rst hour of ischemic process, and the other one died 
at the 4th hour of ischemic process. Two new rats were included 
into the study to replace these rats. Relaparotomy after sacrifi c-
ing all animals with excessive anaesthesia usage revealed that rats 
in non-operative control group (Group I) and operative control 
group (Group II) had normal intestines at inspection. In contrast, 
intestines of the rats in group III were dilated, edematous and ob-
viously cyanotic.
D-dimer
In order to identify if there is a rising tendency in D-dimer 
levels at postoperative 1st, 4th and 6th hour in groups II and III, 
Friedman test was conducted. There was no signifi cant rising ten-
dency in the operative control group (Group II) (p = 0.584) (Fig. 1).
Rats who have mesenteric ischemia (Group III – experimental 
group) had a minor increase in D-dimer levels at sixth hour but 
this was not statistically signifi cant (p = 0.717) (Fig. 2).
In addition, Kruskal-Wallis variation analysis was conducted in 
order to compare D-dimer levels at 1st, 4th and 6th hour in Groups 
II and III with basal D-dimer level of group I. There was no signifi -
cant difference between basal D-dimer levels and levels at 1 hour (p 
Basal 1.hour 4.hour 6.hour
0.40
0.36
0.32
0.28
0.24
0.20
D
-d
im
er
 le
ve
l
Time
Fig. 1. Post-op D-dimer levels at group II (p = 0,584, Friedman vari-
ance analyse).
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Fig. 2. Post-op D-dimer levels at group III (p = 0.717, Friedman vari-
ance analyse).
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Fig. 3. Kruskal-Wallis variance analyse (p = 0.703).
Bratisl Lek Listy 2015; 116 (5)
343 – 350
346
= 0.703) (Fig. 3) observed. Similarly, there was no signifi cant dif-
ference between basal level and levels at 4 and 6th hours in groups 
II and III (P= 0.646 vs P= 0.061, respectively) (Figs 4 and 5).
Mean basal D-dimer levels of group I and mean D-dimer levels 
at 1, 4, and 6. hour of group II and III can be found in Table 1.
L-Lactate
Friedman test was conducted in order to identify if there is a 
rising tendency in L-lactate levels which were evaluated at post-
operative 1st, 4th and 6th hour in groups II and III. There was no 
signifi cant rising tendency in the operative control group (Group II) 
(p = 0.097) (Fig. 6) observed. In the rats with mesenteric ischemia 
(Group III), mean L-lactate levels began to rise at fourth hour and 
this increase continued at 6th hour (p = 0.0001) (Fig. 7). In this 
group, paired comparison of mean L-lactate levels at 1st, 4th and 
6th hours were conducted using Wilcoxon test and p < 0.017 was 
determined to be signifi cant. According to this, L-lactate levels at 
4th hour rised signifi cantly when compared with fi rst hour (p = 
0.005), and this rise was still signifi cant at 6th hour when com-
pared with 4th hour levels (p = 0.007).
Kruskal-Wallis variation analysis was conducted in order to N = 10
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Fig. 4. Kruskal-Wallis variance analyse (p = 0.646).
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Fig. 5. Kruskal-Wallis variance analyse (p = 0.061)
D-dimer       
                            
Group I      
(mean±SD)    
Group II        
(mean±SD)
Group III       
(mean±SD)
p
basal                    0.23±0.06 –                 –
1st hour           –                    0.26±0.13 0.28±0.15      = 0.703
4th hour –                    0.24±0.07 0.25±0.07      = 0.646
6th hour           –                    0.22±0.04 0.31±0.13      = 0.061
Tab. 1. Mean D-dimer levels.
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Fig. 6. Post-op L-lactate levels at group III (p = 0.097, Friedman vari-
ance analyse).
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Fig. 7. Post-op L-lactate levels at group III (p = 0.0001, Friedman vari-
ance analyse). Wilcoxon (post hoc): 1st hour L-lactate vs 4th hour p = 
0.005, 4th hour vs 6th hour p = 0.007.
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compare postoperative 1, 4, and 6th hour L-lactate levels of groups 
II and III with basal L-lactate levels of group I. Accordingly, there 
was no signifi cant difference between L-lactate levels at fi rst hour 
and basal L-lactate levels (p = 0.297) (Fig. 8). In contrast, L-lactate 
levels at hours 4 and 6 of groups II and III was signifi cantly dif-
ferent from basal L-lactate levels (p = 0.0001 vs p = 0.0005, re-
spectively) (Figs 9 and 10). After lowering the signifi cancy level, 
paired comparison of L-lactate levels between groups with Mann–
Whitney U test revealed that there was no signifi cant difference 
between Group II L-lactate levels and 4th hour mean basal levels 
(p = 0.315), but mean L-lactate levels of group III were increased 
signifi cantly compared to mean basal levels and group II averages 
(p = 0.0001 and p =0.0002, respectively). Similarly, there was no 
signifi cant difference between mean basal levels at 6th hour and 
group II L-lactate levels (p = 0.481), but mean L-lactate levels 
of group III were found to be signifi cantly increased compared 
to basal levels and mean levels of group II (p = 0.0001 ad p = 
0.0001, respectively). Mean basal L-lactate levels of group I and 
mean L-lactate levels of group II and III at postoperative 1st, 4th 
and 6th hours are shown in Table 2.
Histopathological assessment
Intestinal samples gathered from animals with mesenteric 
ischemia were examined under light microscope following stain-
ing process with haematoxylin-eosin. Accordingly, apart from 
mucosal destruction accompanying transmural tissue necrosis, 
surface epithelium and intestinal crypts were destructed and villi 
were totally lost (Fig. 11).
Discussion
This study shows that blood L-lactate levels of the SMA oc-
cluded rats increased signifi cantly either inside the group and in 
addition when compared to basal values and mean values of opera-
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Fig. 8. Post-op 1st hour L-lactate levels and basal L-lactate levels (p 
= 0.297, Kruskal-Wallis variance analyse).
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Fig. 9. Post-op 4th hour L-lactate levels and basal L-lactate levels (p 
= 0.0001, Kruskal-Wallis variance analyse).
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Fig. 10. Post-op 6th hour L-lactate levels and basal L-lactate levels (p 
= 0.0005, Kruskal-Wallis variance analyse).
L-lactate       Group I       
(mean±SD)   
Group II              
(mean±SD)     
Group III
(mean±SD)
p
basal                    0.55±0.13  –                         –
1st hour           –                    0.51±0.15           0.53±0.15      = 0.297 
4th hour           –                    0.63±0.29           1.49±0.57 = 0.0001
+ = 0.315
* = 0.0001
§ = 0.0002
6th hour           –                    0.67±0.25           4.12±1.85 = 0.0005
+ = 0.481
* = 0.0001
§ = 0.0001
Tab. 2. Mean L-lactate levels.
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tive control group starting from 4th hour of the mesenteric ischemia 
and this increase continued at 6th hour. In contrast, serum D-dimer 
levels did not differ signifi cantly in animals with acute mesenteric 
ischemia when compared to itself, mean basal levels and 1st, 4th 
and 6th hour levels of operative control group.
As a fatal disease, incidence of mesenteric ischemia tends to 
rise, but it constitutes only one in every 1000 hospitalized patients 
and 1–2 % of hospitalized patients referred with abdominal pain 
(4). Despite the improvements in medical diagnosis and treatment, 
mortality rates are around 70 % (1–4). It is clear that this mortal-
ity rate is far higher when patients who died before diagnosis are 
taken into consideration (5). Previous studies showed that only 
one third of the patients could be diagnosed correctly before death 
(5, 17). In Swedish autopsy studies, it is shown that real mortality 
rate of mesenteric ischemia can be more than 90 %, and 33 % of 
the patients could be diagnosed before death (8). In many studies 
it is reported that delays in establishing the AMI diagnosis reduce 
the survival chance and morbidity signifi cantly (4, 6, 18–20). In 
accordance withthis knowledge, with its high mortality and mor-
bidity rates, acute mesenteric ischemia needs rapid and correct 
diagnosis in order to begin treatment immediately.
Clinical diagnosis of acute mesenteric ischemia is hard to es-
tablish, especially in earlier stages of the disease. Findings at the 
time of referral are usually non-spesifi c. Nausea and vomiting 
accompanying to normal abdominal examination usually causes 
patients to be diagnosed as acute gastroenteritis. Lack of bowel 
sounds and fi ndings like occult blood in stool does not show up 
at earlier stages and when found they usually indicate irreversible 
intestinal damage. There are no specifi c laboratory tests to exclude 
acute mesenteric ischemia and especially some of the tests can be 
deceptive. For example, nearly half of the patients have hyper-
amylasemia and this can mislead a physician to acute pancreatitis.
Most of the patients referred with acute abdominal pain un-
dergo abdominal X-rays. At earlier stages of the disease, these are 
rarely diagnostic (4, 21). Even though Doppler ultrasonography is 
useful in complete obstruction of proximal SMA, it is usually used 
for diagnosis of chronic mesenteric ischemia (3, 4, 22). Helical 
computerized tomography and improvements of rapid intravenous 
contrast agent injection protocols made imaging of the mesenteric 
vessels easier. Because multi-slice spiral CT and magnetic reso-
nance angiography can create high defi nition functional images 
that can show low oxygen saturations, it is promising when com-
pared to conventional CT (3–5, 23, 24). But these techniques are 
not widely used to become a standart.
Selective mesenteric angiography is considered golden stan-
dart in the diagnosis of mesenteric ischemia (3–6). Studies inves-
tigating the place of angiography in AMI diagnosis have shown 
90–100 % sensitivity and 100 % specifi city (6, 25). However, not 
many hospitals and emergency wards have the opportunity to use 
angiography in patients with suspected AMI. Moreover, selective 
mesenteric angiography which is considered a golden standard 
has many disadvantages including its potential nephrotoxicity, 
being expensive and a technique that takes time (4–6). Therefore, 
emergency medicine physicians need faster and simpler methods 
in AMI suspected patients.
Patients referredto emergency ward with abdominal pain are 
asked for a series of biochemical laboratory tests. Most frequently 
encountered laboratory anomalies are leukocytosis and metabolic 
acidosis (7). Besides, there have been lotof standard enzyme stud-
ies including inorganic phosphate and creatinine kinase, lactate 
dehydrogenase, and aspartate aminotransferase in patients with 
suspected AMI (6, 14, 26). Since most of these tests are abnor-
mal in these patients, none of these tests are specifi c and sensitive 
enough to make a diagnosis in early stages. Recently, some cyto-
solic enzymes like glutathione S-transferase and some biochemical 
parametres located in intestinal mucosal villi like intestinal fatty 
acid binding protein (I-FABP) are being questioned for usage in 
AMI as a serological indicator (27, 28). Although these studies 
have promising results, their usage in clinic practice does not seem 
to be possible and practical. Besides, there are studies about the 
usage of D-dimer and L-lactateint AMI diagnosis and despite fi rst 
ones had signifi cant results, especially the latest studies are con-
troversial (4, 10–12, 16, 29–32).
D-dimer is an antigenic product which is the result of a deg-
radation process of cross linked fi brin clot via enzyme plasmin. 
As an indicator of ongoing thrombus formation and degradation, 
most common usage area of systemic D-dimer measurements at 
emergency wards are venous thromboembolic issues like pul-
monary embolism and acute deep vein thrombosis and acute 
coronary syndromes (33, 34). Recent studies from Acosta et al. 
show that D-dimer can be used in patients with suspected AMI 
for exclusion (10, 29). In one of their studies, it is reported that 
the tests were performed in perioperative period but there is no 
description about when the tests were exactly performed (29). In 
their other study, blood was taken in order to analyse D-dimer 
levels of 101 patients within 24 hours from the onset of abdomi-
nal pain and 9 of them were found to be SMA occluded and in 
these patients median D-dimer levels were elevated signifi cantly 
(10). In a more recent prospective study, D-dimer was analysed 
alongside with alpha-glutathion S-transferase, I-FABP, creatinine 
kinase, lactate dehydrogenase and alkaline phosphatase and only 
Fig. 11. Mucosal destruction accompanying transmural tissue necro-
sis, surface epithelium and intestinal crypts were destructed and villi 
were totally lost.
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D-dimer was found to be relevant with AMI but this test was not 
specifi c enough for the diagnosis (13). In experimental studies, 
D-dimer levels were tested at different time points after SMA oc-
clusion and Altinyollar et al. and Kurt et al. reported signifi cant 
elevation 30 minutes and 2 hours after ischemia, respectively 
(12, 30). In both studies different animal groups were used for 
different ischemia periods, so it was not possible to evaluate the 
changes in D-dimer levels with ongoing ischemia in a specifi c 
group. In another study, SMA occluded animals were compared 
intergroup and with controls following ischemia and it was found 
that D-dimer levels can’t be used as an independent parameter in 
early AMI diagnosis (16). In our study, with blood taken from a 
group of SMA occluded animals, D-dimer levels were analysed 
at 1st, 4th and 6th hour and these results were compared with an 
operative control group and a control group from whom the basal 
samples were taken. In addition, evaluations were made among 
the groups. In conclusion, these comparisons are not showing a 
signifi cant difference (Figs 1–5, Tab. 1). Elevated D-dimer lev-
els in the studies may be due to time that passed between testing 
and the onset of pain and existing venous thrombosis. Thus, it is 
reported in a study that 9 of the test samples were taken at emer-
gency ward and 5 were taken at general surgery ward or intensive 
care unit (29). In other studies D-dimer tests were made within 
24 hours from the onset of abdominal pain, so it is hard to evalu-
ate if this test can be used for early diagnosis (10, 13). Previous 
studies have shown similar results in the meaning of D-dimer 
elevations in SMA occluded rats, but in our study this elevation 
was not statistically signifi cant. In addition, different techniques 
and different monoclonal antibodies are being used at different 
D-dimer analyses and this can be the cause of encountered varia-
tions of results (34). In our study, quantitative assay of D-dimer 
was made with immunoturbidimetric method. Despite ELISA is 
being considered a golden standart for D-dimer analyses, immu-
noturbidimetric analyses are preferable at emergency wards be-
cause of their faster and less complex nature and high sensitivity 
and specivity (34).
Metabolic acidosis is considered an indicator of acute mes-
enteric ischemia for the last 3 decades (38). Considering the indi-
cators of metabolic acidosis, L-lactate is known to be one of the 
most practical ways to evaluate laboratory circumstances (4, 31). 
Because mammals only have L-lactate dehydrogenase, pyruvate 
degradation via this enzyme ends up with L-lactate in cellular 
hypoxia. Previous clinical studies have shown that lactate levels 
rise in 90 % of the patients following acute mesenteric ischemia 
and it is reported that there is a correlation with this elevation and 
penetration of the ischemia (4, 31). In two recent experimental 
studies, it is shown that blood lactate levels were elevated sig-
nifi cantly following mesenteric ischemia (16, 32). In contrast, in 
another experimental study, blood lactate levels failed to achieve 
a signifi cancy level (11). These researchers came to a decision 
that lactate might got elevated due to venous stasis at blood sam-
pling. In our research, L-lactate levels were analysed from blood 
samples of a group of rats taken at 1st, 4th and 6th hour and results 
were compared with an operative control group and basal values. 
In addition, comparisons among the groups were made at given 
time-points. Accordingly, there was no signifi cant rising tendency 
in operative control group (Group II) (Fig. 6). However, L-lactate 
levels of mesenteric ischemia group (Group III, research group) 
started elevating at 4th hour and this rise continued at 6th hour 
(Fig. 7). Moreover, when we compared 4th and 6th hour L-lactate 
levels of groups II and III with basal values, there was a signifi -
cant difference (Figs 9 and 10). Besides, mean L-lactate levels of 
group III were found signifi cantly elevated when compared with 
both mean levels of groups I and II. Similarly, there was no sig-
nifi cancy between 6th hour mean basal levels and L-lactate levels 
of group II, but mean L-lactate levels of group III were found to 
be signifi cantly elevated when compared to mean basal levels and 
mean group II levels (Tab. 2). 
Blood L-lactate levels were determined from blood taken into 
capillary tubes with the help of immobilised enzyme electrode 
technology using YSI 1500 Sport portative lactate analyzer (Yel-
low Springs Instruments Inc., Ohio-USA). Twenty-fi ve μL blood 
is enough for the device. Results are acquired within 60 seconds 
in automatic calibration mode. In a study that compares lactate 
analysers in the presence of hemoglobine basis oxygen transport-
ers, it is reported that YSI 1500 Sport portative lactate analyser 
gave the most correct results (39). When the importance of early 
diagnosis of AMI suspected patients is considered, this method 
is suitable for usage at emergency setup because it is portative 
and its giving fast and correct results. Previous clinical studies 
have reported that lactate levels have 100 % sensitivity but 42 % 
specifi city in mesenteric ischemia early diagnosis (4, 31). When 
all taken together, it is clear that L-lactate levels are important to 
lead the patients with AMI suspicion to more complex and inva-
sive diagnostic methods.
As a result, in rats with SMA occlusion serum D-dimer levels 
were not increased signifi cantly when compared either with the 
group or with the basal values of the control group and values in 
operative control group. Therefore, it is concluded that D-dimer 
is not a useful marker at the early diagnosis of AMI. On the other 
hand, it is revealed that blood L-lactate levels began to increase 
signifi cantly following 4th hour of mesenteric ischemia and it is 
shown that this increase continued at the 6th hour. In addition, 
considering the utmost importance of the early diagnosis in pa-
tients with the clinical suspicion of AMI, L-lactate seems to be 
a suitable marker to use in emergency departments because it is 
measured by a portable device that gives fast and accurate results. 
Nevertheless, our results need to be supported by clinical studies 
with larger patient series.
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